Cargando…
Outcome measures for children with mitochondrial disease: consensus recommendations for future studies from a Delphi-based international workshop
Although there are no effective disease-modifying therapies for mitochondrial diseases, an increasing number of trials are being conducted in this rare disease group. The use of sensitive and valid endpoints is essential to test the effectiveness of potential treatments. There is no consensus on whi...
Autores principales: | Koene, Saskia, van Bon, Lara, Bertini, Enrico, Jimenez-Moreno, Cecilia, van der Giessen, Lianne, de Groot, Imelda, McFarland, Robert, Parikh, Sumit, Rahman, Shamima, Wood, Michelle, Zeman, Jiri, Janssen, Anjo, Smeitink, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326961/ https://www.ncbi.nlm.nih.gov/pubmed/30027425 http://dx.doi.org/10.1007/s10545-018-0229-5 |
Ejemplares similares
-
Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation
por: Verhaak, Christianne, et al.
Publicado: (2016) -
Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
por: Koene, Saskia, et al.
Publicado: (2010) -
Mitochondrial medicine
por: Koene, Saskia, et al.
Publicado: (2011) -
Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus
por: De Vries, Maaike C., et al.
Publicado: (2020) -
Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients
por: Smeitink, Jan, et al.
Publicado: (2019)